Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Anticancer Research|April 7, 2019
Influence of Sorafenib on Host Immunity in Patients with Liver Cirrhosis With Advanced Hepatocellular Carcinoma Stratified by EtiologyHidenari Nagai, Takanori Mukozu, Kojiro Kobayashi, et al.Ultrasound Quarterly|April 11, 2018
Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric ImagingNoritaka Wakui, Hidenari Nagai, Yasushi Matsukiyo, et al.Experimental and Therapeutic Medicine|August 13, 2013
Mucinous cystadenocarcinoma of the appendix in which contrast-enhanced ultrasonography was useful for assessing blood flow in a focal nodular lesion in the tumor cavity: A case reportNoritaka Wakui, Mitsuru Fujita, Yoshiya Yamauchi, et al.Ultrasound in Medicine & Biology|October 28, 2025
The Bubble-Destruction Curve Obtained Using Contrast-Enhanced Ultrasound is Useful for Assessing Liver Fibrosis and Identifying At-risk MASH in Patients With MASLDNoritaka Wakui, Yu Ogino, Naohisa Kamiyama, et al.European Journal of Gastroenterology & Hepatology|September 28, 2022
Measurement of skeletal muscle volume is useful for predicting prognosis in patients with liver cirrhosisTeppei Matsui, Hidenari Nagai, Gou Watanabe, et al.Ultrasound in Medicine & Biology|April 30, 2019
Flash Imaging Used in the Post-vascular Phase of Contrast-Enhanced Ultrasonography is Useful for Assessing the Progression in Patients with Hepatitis C Virus-Related Liver DiseaseNoritaka Wakui, Hidenari Nagai, Naoyuki Yoshimine, et al.Oncology|June 26, 2023
Effects of Lenvatinib on Skeletal Muscle Volume and Cardiac Function in Patients with Hepatocellular CarcinomaHidenari Nagai, Makoto Amanuma, Takanori Mukozu, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 14, 2021
Usefulness of virtual touch tissue quantification for predicting the presence of esophageal varices in patients with liver cirrhosisTeppei Matsui, Hidenari Nagai, Gou Watanabe, et al.Cancer Chemotherapy and Pharmacology|October 10, 2021
Adaptation of lenvatinib treatment in patients with hepatocellular carcinoma and portal vein tumor thrombosisTakanori Mukozu, Hidenari Nagai, Daigo Matsui, et al.Hepatology Communications|February 7, 2018
Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver diseaseFumika Shigiyama, Naoki Kumashiro, Yasuhiko Furukawa, et al.Pageof 7